Povetacicept

DB18996InvestigationalProtein Based Therapies

Povetacicept is under investigation in clinical trial NCT05757570 (An Open-label Study of Povetacicept in Subjects With Autoimmune Cytopenias).

Mechanism: Pharmacologically active on Tumor necrosis factor ligand superfamily member 13B and Tumor necrosis factor ligand superfamily member 13
Curator reviewed
Code names: ALPN-303

Resolves to

Compound

Targets

What you can answer from here — as of July 09, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

8Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Povetacicept, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.